全部文献期刊会议图书|学者科研项目
中外文文献  中文文献  外文文献
作者:... Dong Chen , Xiong-ying Jiang , Lin-feng Xu
来源:[J].Academic Radiology(IF 1.914), 2018, Vol.25 (4), pp.423-429
摘要:Rationale and Objective(#br)The objective of this study was to analyze prognostic factors for survival after transarterial chemoembolization (TACE) combined with sorafenib for hepatocellular carcinoma (HCC) of Barcelona Clinic Liver Cancer (BCLC) stages B and C.(#br)Material...
作者:Lin-Feng Xu , Wen-Jing Chu ...
来源:[J].Neuropharmacology(IF 4.114), 2006, Vol.50 (8), pp.934-940
摘要:Abstract(#br)The protopine isolated from a Chinese herb Dactylicapnos scandens Hutch was identified as an inhibitor of both serotonin transporter and noradrenaline transporter in vitro assays. 5-hydroxy-DL-tryptophan(5-HTP)-induced head twitch response (HTR) and tail suspension t...
作者:... Yao-Ting Chen , Lin-Feng Xu , Jin-Hua Huang
来源:[J].International Journal of Hyperthermia(IF 2.591), 2019, Vol.36 (1), pp.840-852
摘要:Abstract(#br)Purpose:(#br) To compare the predictive value of albumin-bilirubin (ALBI) grade, platelet-ALBI (PALBI) grade and Child-Turcotte-Pugh (CTP) class in patients with large hepatocellular carcinoma (HCC) after transarterial chemoembolization (TACE) combined with micr...
作者:... Yao-ting Chen , Lin-feng Xu , Jin-hua Huang
来源:[J].European Radiology(IF 3.548), 2020, Vol.30 (3), pp.2377-2390
摘要:Abstract(#br)Objectives(#br)To develop a prognostic nomogram based on the albumin–bilirubin (ALBI) grade for prediction of the long-term survival of patients with intermediate-stage hepatocellular carcinoma (HCC) after transarterial chemoembolization combined with microwave ...
作者:Lin-Feng Xu , Hui-Bo Lian ...
来源:[J].Asian Journal of Andrology(IF 2.14), 2017, Vol.19 (4), pp.468-472
摘要:This study was designed to define possible preoperative predictors of positive surgical margin after laparoscopic radical prostatectomy. We retrospectively analyzed the records of 296 patients with prostate cancer diagnosed by prostate biopsy, and eventually treated with laparosc...
作者:... Si-Nan Hou , Yao-Ting Chen , Lin-Feng Xu
来源:[J].OncoTargets and Therapy(IF 2.073), 2018, Vol.2018 (default), pp.7883-7894
摘要:Objective To compare the clinical efficacy and safety of transcatheter hepatic arterial infusion chemotherapy (HAIC) with those of sorafenib in the treatment for hepatocellular carcinoma (HCC) of Barcelona Clinic Liver Cancer (BCLC) stage C.Methods The potentially relevant studie...
作者:Lin-feng Xu , Wei-dong Wang ...
来源:[J].Journal of Cancer Research and Clinical Oncology(IF 2.914), 2017, Vol.143 (2), pp.199-207
摘要:Abstract(#br) Purpose(#br)To study whether transarterial embolization (TAE) with RNA interference (RNAi) targeting hypoxia-inducible factor-1α (HIF-1α) can improve efficacy of TAE in treating hepatocellular carcinoma (HCC).(#br) Materials and methods(#br)CBRH-7919 rat hepato...
作者:Lin-feng Xu , Juan Zhang ...
来源:[J].Frontiers in Oncology, 2019, Vol.9
摘要:Non-small-cell lung cancer (NSCLC) is the predominant form of lung cancer, and it is regulated by a complex signal transduction network. Single-agent targeted therapy often results in acquired resistance, which leads to treatment failure. In this study, we demonstrated that a com...
作者:Lin-feng Xu , Hong-liang Sun
来源:[J].Journal of Cancer Research and Clinical Oncology(IF 2.914), 2013, Vol.139 (4), pp.653-659
摘要:Abstract(#br) Purpose(#br)This meta-analysis was designed to compare the effectiveness of the combination of transarterial chemoembolization (TACE) and percutaneous radiofrequency ablation (PRFA) with that of TACE and PRFA monotherapy in hepatocellular carcinoma (HCC).(#br) ...
作者:Lin-feng Xu , Hong-liang Sun ...
来源:[J].Journal of Cancer Research and Clinical Oncology(IF 2.914), 2013, Vol.139 (12), pp.2021-2033
摘要:Abstract(#br) Purpose(#br)To compare comprehensively the benefits of radiofrequency ablation (RFA) and percutaneous ethanol injection (PEI) with those of surgical resection (SR) in early-stage hepatocellular carcinoma (HCC).(#br) Methods(#br)The potentially relevant studies ...

我们正在为您处理中,这可能需要一些时间,请稍等。

资源合作:cnki.scholar@cnki.net, +86-10-82896619   意见反馈:scholar@cnki.net

×